Renibus Therapeutics Announces Breakthrough Therapy Designation from US FDA for [...]
Renibus Reports Positive Final Results from Phase 2 Study [...]
Renibus Therapeutics Announces Presentation at 22nd Annual Needham Virtual [...]
Renibus Therapeutics Announces Presentation at Oppenheimer 33rd Annual Healthcare [...]
Renibus Therapeutics Announces Participation in the SVB Securities Global Biopharma [...]
Renibus Therapeutics Announces Oral Presentation on RBT-1 Phase 2 [...]
Renibus Therapeutics Announces Positive 30-Day Topline Data from RBT-1 [...]
Renibus Therapeutics Strengthens Leadership Team with Asha Ramdas as [...]
Renibus Therapeutics Raises $33 million Bridge Financing to Advance [...]
Renibus Therapeutics Presents Interim Phase 2 Data: RBT-1 Improves [...]